Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gold Glyconanoparticles Combined with 91-99 Peptide of the Bacterial Toxin, Listeriolysin O, Are Efficient Immunotherapies in Experimental Bladder Tumors.
Terán-Navarro H, Zeoli A, Salines-Cuevas D, Marradi M, Montoya N, Gonzalez-Lopez E, Ocejo-Vinyals JG, Dominguez-Esteban M, Gutierrez-Baños JL, Campos-Juanatey F, Yañez-Diaz S, Garcia-Castaño A, Rivera F, Duran I, Alvarez-Dominguez C. Terán-Navarro H, et al. Cancers (Basel). 2022 May 13;14(10):2413. doi: 10.3390/cancers14102413. Cancers (Basel). 2022. PMID: 35626016 Free PMC article.
Diabetes mellitus following cisplatin treatment.
Nan DN, Fernández-Ayala M, Vega Villegas ME, Garcia-Castaño A, Rivera F, Lopez-Brea M, González-Macías J. Nan DN, et al. Acta Oncol. 2003;42(1):75-8. doi: 10.1080/0891060310002276. Acta Oncol. 2003. PMID: 12665335
Gold glyconanoparticles coupled to listeriolysin O 91-99 peptide serve as adjuvant therapy against melanoma.
Calderon-Gonzalez R, Terán-Navarro H, García I, Marradi M, Salcines-Cuevas D, Yañez-Diaz S, Solis-Angulo A, Frande-Cabanes E, Fariñas MC, Garcia-Castaño A, Gomez-Roman J, Penades S, Rivera F, Freire J, Álvarez-Domínguez C. Calderon-Gonzalez R, et al. Nanoscale. 2017 Aug 3;9(30):10721-10732. doi: 10.1039/c7nr02494k. Nanoscale. 2017. PMID: 28714508
Dendritic cell therapy in melanoma.
Alvarez-Dominguez C, Calderón-Gonzalez R, Terán-Navarro H, Salcines-Cuevas D, Garcia-Castaño A, Freire J, Gomez-Roman J, Rivera F. Alvarez-Dominguez C, et al. Ann Transl Med. 2017 Oct;5(19):386. doi: 10.21037/atm.2017.06.13. Ann Transl Med. 2017. PMID: 29114544 Free PMC article. Review.
Pre-clinical development of Listeria-based nanovaccines as immunotherapies for solid tumours: insights from melanoma.
Terán-Navarro H, Calderon-Gonzalez R, Salcines-Cuevas D, García I, Marradi M, Freire J, Salmon E, Portillo-Gonzalez M, Frande-Cabanes E, García-Castaño A, Martinez-Callejo V, Gomez-Roman J, Tobes R, Rivera F, Yañez-Diaz S, Álvarez-Domínguez C. Terán-Navarro H, et al. Oncoimmunology. 2018 Nov 10;8(2):e1541534. doi: 10.1080/2162402X.2018.1541534. eCollection 2019. Oncoimmunology. 2018. PMID: 30713801 Free PMC article.
Long-term results of a phase II trial of induction chemotherapy with uracil-ftegafur (UFT), vinorelbine, and cisplatin (UFTVP) followed by radiotherapy concomitant with UFT and carboplatin (RT/UFTJ) in a primary site preservation setting for resectable locally advanced squamous cell carcinoma of larynx and hypopharynx.
Rivera F, Vega-Villegas ME, López-Brea MF, García-Castaño A, de Juan A, Collado A, Galdós P, Rubio A, del Valle A, Rama J, Sanz-Ortiz J. Rivera F, et al. Laryngoscope. 2004 Jul;114(7):1163-9. doi: 10.1097/00005537-200407000-00006. Laryngoscope. 2004. PMID: 15235341 Clinical Trial.
Long term results of a phase II trial of induction chemotherapy with uracil-ftegafur (UFT), vinorelbine and cisplatin (UFTVP) followed by radiotherapy concomitant with UFT and carboplatin (RT/UFTJ) in non-resectable locally advanced (stage IV-B) squamous cell head and neck carcinoma and peripheral blood stem cell support (PBSCS) with febrile neutropenia.
Rivera F, Vega-Villegas ME, López-Brea MF, García-Castaño A, de Juan A, Ramos FJ, Collado A, Galdós P, Rubio A, del Valle A, Rama J, Mayorga M, Sanz-Ortiz J. Rivera F, et al. Clin Transl Oncol. 2007 Jan;9(1):40-7. doi: 10.1007/s12094-007-0008-5. Clin Transl Oncol. 2007. PMID: 17272229 Clinical Trial.
Immune-related adverse events in patients with solid-organ tumours treated with immunotherapy: a 3-year study of 102 cases from a single centre.
Gonzalez-Mazón I, Sánchez-Bilbao L, Martín-Varillas JL, García-Castaño A, Delgado-Ruiz M, Bernat Piña I, Hernández JL, Castañeda S, Llorca J, González-Gay MA, Blanco R. Gonzalez-Mazón I, et al. Clin Exp Rheumatol. 2021 May-Jun;39(3):612-620. doi: 10.55563/clinexprheumatol/o5nvgv. Epub 2020 Sep 3. Clin Exp Rheumatol. 2021. PMID: 32896258 Free article.
64 results